On the other hand, the plasma concentrations of pro-hepcidin, the precursor to hepcidin, were not significantly altered in a cohort of 29 ALS patients (from nine to 28 months post-diagnosis) compared to control group. The gene discussed is HAMP; the disease is amyotrophic lateral sclerosis.